CRISPR raises $113.8M in follow-on

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) raised $113.8 million on Jan. 4 through the sale of 5 million shares at $22.75 in a follow-on underwritten by Goldman Sachs, Piper Jaffray, Barclays and Guggenheim. The price is a 10% discount to CRISPR’s close of $25.17 on Jan. 2, before the company proposed to raise $100 million...